Data Watch: Most People Support Restrictions on Direct-to-Consumer Advertising of New Drugs

2005 ◽  
Vol 33 (10) ◽  
pp. 72
2002 ◽  
Vol 21 (2) ◽  
pp. 194-201 ◽  
Author(s):  
Joel Lexchin ◽  
Barbara Mintzes

There is little rationale for direct-to-consumer advertising of prescription drugs. Most new drugs offer little if any therapeutic advantage over existing products. Direct-to-consumer advertisements frequently downplay safety information. Physicians are highly ambivalent about prescribing advertised drugs requested by patients. There is no evidence that direct-to-consumer advertising results in any improvement in health outcomes.


2009 ◽  
Vol 26 (4) ◽  
pp. 251-258 ◽  
Author(s):  
Lawrence S. Silver ◽  
Robert E. Stevens ◽  
David Loudon

2014 ◽  
Vol 120 ◽  
pp. 1-11 ◽  
Author(s):  
Amie C. O'Donoghue ◽  
Pamela A. Williams ◽  
Helen W. Sullivan ◽  
Vanessa Boudewyns ◽  
Claudia Squire ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document